Latest Insider Transactions at Veracyte, Inc. (VCYT)
This section provides a real-time view of insider transactions for Veracyte, Inc. (VCYT). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of VERACYTE, INC. to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of VERACYTE, INC.'s insiders and make more informed investment decisions.
Insider Transaction List
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Jan 04
2021
|
Kevin K Gordon Director |
BUY
Exercise of conversion of derivative security
|
Direct |
10,000
+50.0%
|
$70,000
$7.39 P/Share
|
|
Dec 29
2020
|
Bonnie H Anderson Director |
BUY
Exercise of conversion of derivative security
|
Direct |
31,313
+7.17%
|
$93,939
$3.34 P/Share
|
|
Dec 04
2020
|
Giulia C Kennedy Chief Scientific & Med Officer |
SELL
Open market or private sale
|
Direct |
14,015
-5.33%
|
$784,840
$56.73 P/Share
|
|
Dec 04
2020
|
Giulia C Kennedy Chief Scientific & Med Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
13,468
+4.86%
|
$148,148
$11.75 P/Share
|
|
Dec 02
2020
|
Mark Ho |
SELL
Payment of exercise price or tax liability
|
Direct |
152
-0.8%
|
$8,360
$55.08 P/Share
|
|
Dec 02
2020
|
Keith Kennedy COO / CFO |
SELL
Payment of exercise price or tax liability
|
Direct |
944
-0.79%
|
$51,920
$55.08 P/Share
|
|
Dec 02
2020
|
John Walter Hanna Jr Chief Commercial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
465
-0.63%
|
$25,575
$55.08 P/Share
|
|
Dec 02
2020
|
Bonnie H Anderson Director |
SELL
Payment of exercise price or tax liability
|
Direct |
1,976
-1.13%
|
$108,680
$55.08 P/Share
|
|
Dec 02
2020
|
Giulia C Kennedy Chief Scientific & Med Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
540
-0.68%
|
$29,700
$55.08 P/Share
|
|
Nov 12
2020
|
Kevin K Gordon Director |
SELL
Open market or private sale
|
Direct |
10,000
-90.97%
|
$470,000
$47.4 P/Share
|
|
Nov 12
2020
|
Kevin K Gordon Director |
BUY
Exercise of conversion of derivative security
|
Direct |
10,000
+50.0%
|
$70,000
$7.39 P/Share
|
|
Nov 11
2020
|
Mark Ho |
SELL
Open market or private sale
|
Direct |
13,875
-42.1%
|
$624,375
$45.0 P/Share
|
|
Nov 10
2020
|
Bonnie H Anderson Director |
BUY
Bona fide gift
|
Indirect |
45,812
+32.35%
|
-
|
|
Nov 10
2020
|
Bonnie H Anderson Director |
SELL
Bona fide gift
|
Direct |
45,812
-11.0%
|
-
|
|
Nov 10
2020
|
Bonnie H Anderson Director |
SELL
Exercise of conversion of derivative security
|
Direct |
20,000
-2.15%
|
$840,000
$42.41 P/Share
|
|
Nov 10
2020
|
Bonnie H Anderson Director |
BUY
Exercise of conversion of derivative security
|
Direct |
20,000
+7.69%
|
$160,000
$8.86 P/Share
|
|
Nov 06
2020
|
John Walter Hanna Jr Chief Commercial Officer |
SELL
Open market or private sale
|
Direct |
21,250
-11.29%
|
$913,750
$43.8 P/Share
|
|
Nov 06
2020
|
John Walter Hanna Jr Chief Commercial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
21,250
+18.19%
|
$425,000
$20.21 P/Share
|
|
Nov 05
2020
|
John Walter Hanna Jr Chief Commercial Officer |
SELL
Open market or private sale
|
Direct |
6,406
-2.7%
|
$262,646
$41.21 P/Share
|
|
Nov 05
2020
|
John Walter Hanna Jr Chief Commercial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
6,406
+3.89%
|
$44,842
$7.52 P/Share
|
|
Oct 20
2020
|
Mark Ho |
BUY
Exercise of conversion of derivative security
|
Direct |
7,500
+18.54%
|
$45,000
$6.45 P/Share
|
|
Oct 19
2020
|
Fred E Cohen Director |
BUY
Exercise of conversion of derivative security
|
Direct |
10,000
+50.0%
|
$70,000
$7.6 P/Share
|
|
Oct 08
2020
|
Bonnie H Anderson Director |
SELL
Open market or private sale
|
Direct |
50,000
-18.5%
|
$1,900,000
$38.0 P/Share
|
|
Oct 08
2020
|
Bonnie H Anderson Director |
BUY
Exercise of conversion of derivative security
|
Direct |
50,000
+15.61%
|
$400,000
$8.86 P/Share
|
|
Oct 06
2020
|
Giulia C Kennedy Chief Scientific & Med Officer |
SELL
Open market or private sale
|
Direct |
2,500
-3.05%
|
$87,500
$35.21 P/Share
|
|
Oct 06
2020
|
Giulia C Kennedy Chief Scientific & Med Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
2,500
+2.96%
|
$50,000
$20.21 P/Share
|